Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions

BACKGROUND: One objective of the Belgian Rare Diseases plan is to improve patients’ management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developing new financing conditions and establishing reference labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandevelde, Nathalie M., Vermeersch, Pieter, Devreese, Katrien M. J., Vincent, Marie-Françoise, Gulbis, Béatrice, Eyskens, François, Boemer, François, Gothot, André, Van Hoof, Viviane O., Bonroy, Carolien, Stepman, Hedwig, Martens, Geert A., Bossuyt, Xavier, Roosens, Laurence, Smet, Julie, Laeremans, Hilde, Weets, Ilse, Minon, Jean-Marc, Vernelen, Kris, Coucke, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890854/
https://www.ncbi.nlm.nih.gov/pubmed/33596965
http://dx.doi.org/10.1186/s13023-021-01728-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890854/
https://www.ncbi.nlm.nih.gov/pubmed/33596965
http://dx.doi.org/10.1186/s13023-021-01728-1

Ejemplares similares